Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.

Kang S, Kishimoto T. · 2021

Read Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. by Kang S, Kishimoto T. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8273570.txt.

Description

Kang and Kishimoto survey interleukin-6 signalling and the vessel wall in cytokine storms. IL-6 defends the body against infection and injury. It also marks several kinds of cytokine storm.

IL-6 acts directly on vascular endothelial cells. Those cells then release more cytokines and start clotting paths. Leaky vessels and abnormal clotting mark severe storms. A humanised antibody, tocilizumab, blocks the IL-6 receptor. Evidence suggests it can quiet IL-6 signalling in patients. The review ties cell biology to that therapy. It clarifies when blocking IL-6 should help most. Vessel failure is treated as a driver, not a bystander.

Catalog record

CREATORKang S, Kishimoto T.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8273570

Browse the full library · About the Tower of Babel